missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human IGFALS/ALS Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Brand: R&D Systems™ 9917-IA-050
365.43 EUR valid until 2024-12-16
Use promo code "21630" to get your promotional price.
This item is not returnable.
View return policy
Description
- Derived from CHO
- Validated for the following applications: Bioactivity.
Specifications
| P35858-1 | |
| 3483 | |
| 50 μg | |
| 12 months from date of receipt, -20 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution 3 months, -20 °C under sterile conditions after reconstitution. | |
| ACLSD, ALS, Igfals | |
| Human | |
| Lyophilized from a 0.2 μm filtered solution in PBS |
| Bioactivity | |
| 76 to 88 kDa, reducing conditions | |
| Chinese Hamster Ovary cell line, CHO-derived human IGFALS/ALS protein Ala28-Cys605, with a C-terminal 6-His tag | |
| < 0.10 EU per 1 μg of the protein by the LAL method | |
| Unconjugated | |
| Reconstitute at 500 μg/mL in PBS | |
| > 95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining |